17th Annual ALLICENSE Meeting

Event Details

The Deloitte Recap ALLICENSE meeting brings together leading biopharma dealmakers and industry leaders in an open, collaborative forum designed to encourage debate and tackle the significant challenges facing dealmaking teams today.

Celebrating its 17th year in 2013, the ALLICENSE meetings have tracked the successes and setbacks of biotech business development and licensing, including the evolution of best practices as new participants bring innovative approaches to the industry. This year’s forum will examine many facets of the evolving relationship among biotech, traditional pharma, corporate VCs, academia, and payers.